|
Hold on VYN202 phase 1b for psoriasis
|
Thu-03-07-2025, 13:31 PM
Update: VYNE will no longer enrol patients in the Phase 1b psoriasis study of VYN202 for psoriasis, they expect to provide further updates on its plans for the VYN202 program following the release of top-line results from the ongoing Phase 2b study of its lead candidate repibresib gel (formerly VYN201), a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo.
|
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Hold on VYN202 phase 1b for psoriasis - by Fred - Sat-26-04-2025, 11:01 AM
RE: Hold on VYN202 phase 1b for psoriasis - by Fred - Thu-03-07-2025, 13:31 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
ORKA-001 for psoriasis phase 2a | Fred | 0 | 244 |
Mon-21-07-2025, 12:35 PM Last Post: Fred |
|
|
Zoryve for psoriasis phase 3 results | Fred | 3 | 1,096 |
Wed-11-06-2025, 14:16 PM Last Post: Fred |
|
|
Picankibart for psoriasis phase 3 study | Fred | 1 | 640 |
Fri-30-05-2025, 01:03 AM Last Post: mataribot |
|
|
Phase I trial of ASC50 for psoriasis | Fred | 0 | 652 |
Thu-22-05-2025, 12:13 PM Last Post: Fred |
|
|
ORKA-002 for psoriasis phase 1 started | Fred | 0 | 538 |
Wed-21-05-2025, 13:21 PM Last Post: Fred |
Health Boards
